Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan-HCTZ vs Losartan in Essential Hypertension
NCT00307060Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of losartan and hydrochlorothiazide in essential hypertension (2 arms), sponsored by Organon & Co. Primary endpoint: Sitting Diastolic Blood Pressure at 6 weeks. Started Dec 2004; status: completed.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00307060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307060.